Last week, I sat across from a couple in my clinic who had been on the IVF journey for over two years. They were exhausted, emotionally drained, and financially stretched. Yet, what struck me most was not their perseverance, but their confusion. They were bewildered by the medical jargon that had been thrown at them over the years, the terms that were supposed to clarify but only served to complicate. I realized then, as I have many times before, that IVF clinics have a tendency to hide behind medical jargon, creating a barrier between doctors and patients that could be detrimental to the very essence of patient care.
In the world of IVF, we often speak in a language that feels more like a code than a conversation. We talk about “blastocysts” and “intracytoplasmic sperm injection” as if everyone understands these terms intuitively. To us, they are everyday language, but for our patients, they are foreign concepts that require translation. This disconnect is not just a matter of semantics; it is a real barrier to effective communication and patient understanding.
I’ve often pondered why we, as medical professionals, fall into this trap. Perhaps it stems from a desire to maintain a sense of control or authority in a field where uncertainty can be overwhelming. After all, IVF is not a guaranteed path to parenthood. The success rates hover around 30-40% for women under 35, and they decline significantly with age. This reality is hard enough for patients to accept without the added confusion of medical jargon.
When I think about the parallels between my work in IVF and my role as an angel investor, I notice a striking similarity. Just as startups can drown in the buzzwords of the tech world, patients can feel overwhelmed by the medical terms we use. In both spheres, the key to success lies in clear, honest communication. When I mentor founders, I urge them to cut through the jargon and speak plainly about their challenges and solutions. In the same vein, I believe IVF clinics should strive for transparency and simplicity in their communication.
Consider this: a founder I backed recently shared that investors were more receptive when he ditched the complicated tech talk and spoke about his product in terms everyone could understand. His experience echoes what I’ve learned in the clinic. Patients respond better when we explain their options in simple, relatable terms. They don’t need to know every detail of the embryology process; they need to trust that we understand it and that we are on this journey with them.
This is not to say that we should oversimplify or withhold information. On the contrary, patients deserve to know the full scope of their treatment, including the risks, costs, and potential outcomes. What I advocate for is a shift in the way we present this information. We need to focus on the “why” and the “how” rather than the “what.” It’s about painting a picture of the journey rather than inundating them with technical specifics.
For instance, when discussing the option of preimplantation genetic testing (PGT), instead of launching into a technical explanation, I might say, “PGT allows us to screen embryos for genetic conditions, which can increase the chances of a successful pregnancy and a healthy baby. It’s like having an extra layer of assurance in the process.” By framing it this way, patients can grasp the significance without getting lost in the details.
Moreover, our responsibility extends beyond verbal explanations. Written materials, consent forms, and online resources should all reflect this commitment to clarity. When patients take home a brochure or visit our website, they should find information that empowers them, not intimidates them. This is why I am a strong advocate for transparency in all aspects of IVF, including costs and outcomes. It’s a principle I’ve incorporated into my clinic’s operations, as outlined in my previous post, Why My IVF Clinic Doesn’t Fear Transparent Conversations About Costs.
There is an emotional and psychological component to this as well. IVF is a deeply personal and often stressful journey. Patients are not just looking for scientific expertise; they are seeking empathy and support. They want to feel heard and understood, not just treated. In my experience, the most successful patient relationships are those built on trust and open communication.
As I reflect on the lessons from both my medical practice and my investment activities, I am reminded of the importance of managing expectations. In the startup world, unmet expectations can lead to disappointment and failure. Similarly, in IVF, unrealistic expectations can devastate. It’s a topic I explored in a piece titled What Indian Startups Can Learn from IVF Patients About Managing Expectations.
Ultimately, the goal of any IVF clinic should be to demystify the process and empower patients with knowledge that is both accessible and actionable. We must remember that while we may be well-versed in the science, our patients are navigating a new and often daunting journey. It is our duty to guide them with compassion and clarity, ensuring they feel confident and supported every step of the way.
In closing, I call upon my peers in the reproductive medicine community to reevaluate the way we communicate with our patients. Let us not hide behind the veil of medical jargon but instead strive for a partnership rooted in transparency and understanding. After all, the success of our work is not measured solely by pregnancy rates but by the trust and confidence we instill in those who walk this path with us.